Condition

Gastric (Stomach) Cancer clinical trials and research

• 16Clinical trials
• 7Countries

Newest Gastric (Stomach) Cancer clinical trials

All recruiting trials (16)

• Clonal Hematopoiesis Effects with Chemo and Radiation in Solid Cancers

  This study tests whether clonal hematopoiesis affects outcomes for adults with solid cancers who are receiving chemotherapy or radiation.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07675967

• BHB810 in advanced gastric and GEJ cancer (early-phase)

  This study tests whether BHB810 can be safely given every two weeks to adults with advanced gastric or GEJ adenocarcinoma and looks at its effect, how the drug behaves in the body, and patient responses.

  Recruiting at 2 sites Phase 1/2 BigHat Biosciences, Inc. · Duarte, California and 2 other locations · NCT07529808

• First-in-human dose study of DA-3501 for CLDN18.2-positive stomach, GEJ cancer, and pancreatic cancer

  A first-in-human study tests DA-3501 in adults with CLDN18.2-positive advanced stomach/GEJ cancer or pancreatic cancer to find a safe, effective dose.

  Recruiting at 3 sites Phase 1 Dong-A ST Co., Ltd. · Seongnam, Bundang and 2 other locations · NCT07481357

• Gastric cancer characteristics and care patterns in Algeria

  This project collects medical records and short interviews to describe who has gastric cancer and how they are diagnosed and treated at Algerian oncology centers.

  Recruiting Société Algérienne de Formation et Recherche en Oncologie · Algiers, Algeria and 14 other locations · NCT07481110

• Riluzole to prevent thinking and memory problems during chemotherapy

  This pilot trial tests whether riluzole can prevent thinking and memory problems in adults with cancer receiving anthracycline- or platinum-based chemotherapy.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT07447050

• TCC1727 combined with other cancer medicines for adults with advanced solid tumors

  This phase Ib/II trial tests TCC1727 given with benmelstobart, olaparib, or topotecan in adults with advanced solid tumors to find safe doses and see if the combinations help control tumors.

  Recruiting Phase 1/2 Beijing Tide Pharmaceutical Co., Ltd · Beijing, Beijing Municipality and 2 other locations · NCT07371663

• Fruquintinib with trastuzumab and XELOX for first-line treatment of HER2‑positive advanced stomach or GEJ cancer

  This trial will try fruquintinib together with trastuzumab and XELOX to see if it helps people with HER2‑positive advanced stomach or gastroesophageal junction cancer as their first treatment.

  Recruiting Phase 1/2 Henan Cancer Hospital · Zhengzhou, Henan · NCT07334431

• RAK cell therapy for late-stage gastric cancer

  This study will test whether umbilical cord blood–derived RAK cell therapy can help adults with late-stage or recurrent gastric cancer live longer and tolerate treatment after frontline therapies have failed.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07212933

• Best time for minimally invasive local treatment after first-line systemic therapy for limited (oligo) esophageal or stomach cancer

  This trial will test whether giving local treatment (surgery or radiation) earlier or later after first-line systemic therapy works better for people whose esophageal or stomach cancer has spread to only a few sites.

  Recruiting at 4 sites Phase 2 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam and 4 other locations · NCT07000253

• Multigene Methylation Changes and Treatment Response in Gastric Cancer

  This study tests whether changes in blood-based multigene methylation from before to after treatment relate to how well gastric cancer responds to therapy.

  Recruiting at 2 sites Xijing Hospital · Xi'an, Shaanxi and 1 other locations · NCT06979895

• Stool-based multi-target DNA screening for stomach cancer

  This project tests whether a stool multi-target DNA test (detecting Helicobacter pylori genes and methylated DNA markers) can help find stomach cancer earlier in people aged 40 and over.

  Recruiting Fudan University · Tongling · NCT06943807

• Gastric cancer risk in carriers of high-risk Helicobacter pylori variants

  This study will see if people carrying high‑risk genetic subtypes of H. pylori develop gastric cancer or precancerous lesions more often than people without those subtypes.

  Recruiting Fudan University · Tongling · NCT06896370

• Combining XELOX chemotherapy, sintilimab, and hyperbaric oxygen therapy for advanced gastric cancer

  This study is testing a new combination of chemotherapy, an immune therapy, and oxygen treatment to see if it can help people with advanced stomach cancer feel better and improve their treatment outcomes.

  Recruiting Phase 1/2 West China Hospital · Chengdu, Sichuan and 1 other locations · NCT06742411

• Neoadjuvant zolbetuximab with docetaxel, oxaliplatin and S-1 for locally advanced stomach cancer

  This study will test whether adding zolbetuximab to docetaxel, oxaliplatin, and S-1 before surgery helps people with locally advanced, CLDN18.2-positive stomach cancer shrink tumors and have better outcomes.

  Recruiting at 2 sites Phase 1/2 Asan Medical Center · Seoul and 1 other locations · NCT06732856

• Using virtual reality to help manage pain in GI cancer patients

  This study is testing if virtual reality can help people with GI cancer manage their severe abdominal pain better than standard treatments.

  Recruiting Cedars-Sinai Medical Center · Los Angeles, California · NCT04907643

• Research on upper gastrointestinal cancers using tissue and blood samples

  This study is trying to learn more about gastric and esophageal cancers by looking at tissue and blood samples from patients to find out how genes and proteins affect these diseases.

  Recruiting Stanford University · Stanford, California · NCT01048281

Related topics

Quick answers

How many Gastric (Stomach) Cancer clinical trials are recruiting right now?

16, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in China (7 trials), United States (5 trials), South Korea (2 trials), Algeria (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 5, Phase 2: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →